ascopubs.org

DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma Patients had ...
The Brooklyn Paper

Greenpoint residents say DKN Ready Mix concrete facility has brought dust, noise, and health concerns

A new concrete batching facility in Greenpoint is stirring up dust and controversy as locals, outraged by what they say is outright pollution of the air and water, urge regulators to crack down.
Nasdaq

Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

CAMBRIDGE, Mass., Sept. 24, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that ...
Nasdaq

Leap Therapeutics Announces Oprhan Drug Designation of DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

CAMBRIDGE, Mass., June 11, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that the ...
Healio

FDA grants orphan drug status to DKN-01 for certain gastrointestinal cancers

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to DKN-01 for the treatment of gastric or gastroesophageal junction ...
Healio

FDA grants fast track designation to DKN-01 for two gastrointestinal cancers

Please provide your email address to receive an email when new articles are posted on . The FDA granted fast track designation to DKN-01 for the treatment of certain patients with gastric cancer or ...